Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya

East African Medical Journal

Volumn 79, Issue 11, 2002, Pages 567-573

  Makokha, E P ^a,b   Songok, E M ^b   Orago, A A ^c   Koech, D K ^b   Chemtai, A K ^a   Kobayashi, N ^b   Mpoke, S ^b   Tukei, P M ^b   Andayi, F A ^b   Lihana, R W ^b   Adungo, N I ^b   Vulule, J M ^b  

^a MOI UNIVERSITY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c KENYATTA UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS DNA; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BREAST FEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; INFECTION RISK; INFORMED CONSENT; KENYA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; POLYMERASE CHAIN REACTION; PREGNANCY; SHORT COURSE THERAPY; SIDE EFFECT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THIRD TRIMESTER PREGNANCY; VIRUS TRANSMISSION; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; DRUG EFFECT; HEALTH; IMMUNOLOGY; MALE; METHODOLOGY; NEWBORN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT, NEWBORN; KENYA; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PRENATAL CARE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL HEALTH; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION; ZIDOVUDINE;

EID: 0036879210     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v79i11.8800     Document Type: Article

References (25)

1. Castilla, J.A., Rueda, R., Vargas, M.L., Gonzales-Gomez, F. and Garcia-Olivares, E. Decreased levels of circulating CD4+ T lymphocytes during normal pregnancy. J. Reprod. Immunol. 1989; 15:103-111.
2. Rich, K.C., Siegel, M., Jennings, C., Rydman, R.L. and Landay, A.L. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J. Infect. Dis. 1995; 172:1221-1227.
3. Moran, P.J., Welles, S.L. and Williams, M.A. The interrelation of maternal immune competence, HIV-1 viral load, and nutritional status in preventing vertical transmission: an alternative to chemoprophylaxis? Med. Hypothesis. 1998; 5:389-397.
4. Bredberg-Raden, U., Urassa, W., Urassa, E., et. al. Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania. J. AIDS. 1995; 8:182-187.
5. Anonymous. Mother-to-child transmission of human immununodeficiency virus in Italy: temporal trends and determinants of infection. The Italian Collaborative Study on HIV infection in pregnancy. Human Reproduction. 1999; 14:242-246.
6. UNAIDS/WHO: Global HIV/A1DS Epidemic Update: June 2000.
7. WHO/FRH/NUT/CHD/98.4/UNAIDS/98.6/UNICEF/NUT (J); 98-4: HIV and Infant feeding. Geneva, 20-24, April 1998.
8. Newell, M.I. Vertical transmission of HIV-1 infection. Trans. R. Soc. Trop. Med. Hyg. 2000; 94:1-2.
9. Leroy, V., Newell, M.L. and Dabis, F. International multicentre pooled analysis of late postnatal mother-to child transmission of HIV infection. The Lancet. 1998; 352:597-600.
10. Administration of Zidovudine during late pregnancy and delivery to prevent HIV transmission-Thailand. Morb. and Mortal. Weekly Rep. 1998; 47:151-154.
11. Shaffer, N., Chuachoowong, R., Mock, P.A., et al. Short-course Zidovudine for perinatal H1V-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok collaborative Perinatal HIV Transmission Study Group. Lancet. 1999; 353:773-780.
12. Wade, N.A., Birkhead, G.S., Warren, B.L., et al. Abbreviated regimes of Zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N. Engl. J. Med. 1998; 339:1409-1414.
13. Simpson, B.J., Shapiro, E.D. and Andiman, W.A. Reduction of the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered Zidovudine alone. J. Acquir. Immune Defic. Syndr. Hum. Retr. 1997; 14:145-152.
14. Burns, D.N., Nourjah, P., Minkoff, H., Korelitz, J. and Biggar, J.B. Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am. J. Obstet. Gynecol. 1996; 174:1461-1468.
15. Fleury, S. de Boer, R.J., Rizzard, G.P., et al. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of antiretroviral therapy. Nat. Med. 1998; 4:794-801.
16. Lederman, N.M., Connich, E., Landay, A., et al. Immunologic responses associated with 12 weeks of AZT antiretroviral therapy: results from AIDS Clinical Trials Group Protocol 315. J. Infect. Dis. 1998; 178:70-79.
17. Maurer, D., Fetzman, T. and Knapp, A. A single laser flow cytometry method to evaluate the binding of 3 antibodies. J. Immunol. Meth. 1990; 135:43-47.
18. Newell, N.L, Peckham, C. and Lepage, P. HIV-1 infection in pregnancy: implications for mother and children. AIDS. 1999; 4(suppl):S111-S117.
19. Wiktor, S., Ekpin, E., Karon, J., et al. Short course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Còte d' Voire: a randomised trial. Lancet. 1999; 353:781-785.
20. Dabis, F., Leroy, V., Castetbon, K., et al. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS. 2000; 14:1017-1026.
21. Mofenson, L.M., Lambert, J.S., Stiem, E.R., et al. Risk factors for vertical transmission of human immunodeficiency virus type I in women treated with zidovudine. N. Engl. J. Med. 1999; 341:385-393.
22. Bento, J.M., Jose, M.Z., Juana, G., et al. Quantitative alterations of the functionally distinct subset of CD4 and CD8 lymphocytes in asymptomatic HIV infection: Changes in expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J. Acq. Imm. Def. Syndr. & Human Retro. 1997; 12:128-135.
23. Roederer, M., Dubs, J.G., Anderson, M.T., et al. CD4 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 1995; 95:2061-2066.
24. Dyroll-Riise, A.M., Brantsaeter, A.B., Dunlop, O., et al. Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus type 1 positive individuals. Scand. J. Immunol. 2000; 51:195-201.
25. Shapiro, D.E., Sperling, R.S., Mandelbrot, L., Britto, P. and Cunningham, B.E. Risk factors for perinatal human immunodeficiency virus transmission in-patients receiving Zidovudine prophylaxis. Paediatrics AIDS clinical trials group protocol 076 Study group. Obstet. Gynecol. 1999; 94:897-908.